Ting Sun
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Glioma Diagnosis and Treatment
Papers in
- Co-authors
- Wei Yang (12 shared papers)Fenju Liu (3 shared papers)Wei Jian Zhu (1 shared paper)Jianping Cao (1 shared paper)Ye Tian (1 shared paper)Dan J. Raz (6 shared papers)Keqiang Zhang (6 shared papers)Rajendra P. Pangeni (5 shared papers)
- Journals
- International Journal of Radiation Biology (3 papers)Cell Communication and Signaling (3 papers)Toxicology and Applied Pharmacology (2 papers)Journal of Neuro-Oncology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ting Sun
32 papers receiving 812 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 253
- Genetics 53
- Oncology 123
- Molecular Biology 274
- Reproductive Medicine 42
Countries citing papers authored by Ting Sun
This map shows the geographic impact of Ting Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Sun more than expected).
Fields of papers citing papers by Ting Sun
This network shows the impact of papers produced by Ting Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Sun. The network helps show where Ting Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Ting Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 126 | |
| 2 | 2012 | 115 | |
| 3 | 2011 | 76 | |
| 4 | 2011 | 52 | |
| 5 | 2019 | 49 | |
| 6 | 2020 | 38 | |
| 7 | 2022 | 30 | |
| 8 | 2013 | 29 | |
| 9 | 2013 | 28 | |
| 10 | 2020 | 28 | |
| 11 | 2010 | 26 | |
| 12 | 2023 | 25 | |
| 13 | 2013 | 21 | |
| 14 | 2022 | 20 | |
| 15 | 2020 | 18 | |
| 16 | 2011 | 17 | |
| 17 | 2013 | 17 | |
| 18 | 2023 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2021 | 12 |
About Ting Sun
Ting Sun is a scholar working on Genetics, Oncology, Cancer Research, Physiology and Molecular Biology, having authored 33 papers that have together received 828 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (3 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Research Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (253 citations), Genetics (53 citations), Oncology (123 citations), Molecular Biology (274 citations) and Reproductive Medicine (42 citations). Ting Sun has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Wei Yang, Fenju Liu, Wei Jian Zhu, Jianping Cao, Ye Tian, Dan J. Raz, Keqiang Zhang, Rajendra P. Pangeni, Wen-Dong Li and Yanyan Li. Their work appears in journals such as International Journal of Radiation Biology, Cell Communication and Signaling, Toxicology and Applied Pharmacology, Journal of Neuro-Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.